Family · Pharmaceutical analytical standards
Selegiline
An irreversible, selective inhibitor of monoamine oxidase B (MAO-B), the enzyme that breaks down dopamine in the brain; discovered in Hungary in 1961, it is used mainly in Parkinson's disease. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Born in Budapest from the work of pharmacologist József Knoll and chemist Zoltán Ecseri, under the name deprenyl it was the first selective MAO-B inhibitor; today it is also approved for cognitive decline in older dogs.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
